* A new ventricular assist device designed for use in children with heart failure resulted in significantly higher survival than did extracorporeal membrane oxygenation during the bridge to transplantation.
* Serious adverse events, such as bleeding, injection, and stroke, were common in all participants.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados